Literature DB >> 35004954

The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF).

Kenneth I Zheng1, Ming-Hua Zheng1,2,3.   

Abstract

Entities:  

Year:  2021        PMID: 35004954      PMCID: PMC8683932          DOI: 10.21037/hbsn-21-431

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 2.  A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Authors:  Mohammed Eslam; Philip N Newsome; Shiv K Sarin; Quentin M Anstee; Giovanni Targher; Manuel Romero-Gomez; Shira Zelber-Sagi; Vincent Wai-Sun Wong; Jean-François Dufour; Jörn M Schattenberg; Takumi Kawaguchi; Marco Arrese; Luca Valenti; Gamal Shiha; Claudio Tiribelli; Hannele Yki-Järvinen; Jian-Gao Fan; Henning Grønbæk; Yusuf Yilmaz; Helena Cortez-Pinto; Claudia P Oliveira; Pierre Bedossa; Leon A Adams; Ming-Hua Zheng; Yasser Fouad; Wah-Kheong Chan; Nahum Mendez-Sanchez; Sang Hoon Ahn; Laurent Castera; Elisabetta Bugianesi; Vlad Ratziu; Jacob George
Journal:  J Hepatol       Date:  2020-04-08       Impact factor: 25.083

3.  Is cryptogenic cirrhosis different from NASH cirrhosis?

Authors:  Paul J Thuluvath; Sergey Kantsevoy; Avesh J Thuluvath; Yulia Savva
Journal:  J Hepatol       Date:  2017-11-21       Impact factor: 25.083

4.  Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

Authors:  David van der Poorten; Caroline F Samer; Mehdi Ramezani-Moghadam; Sally Coulter; Marina Kacevska; Dennis Schrijnders; Lindsay E Wu; Duncan McLeod; Elisabetta Bugianesi; Mina Komuta; Tania Roskams; Christopher Liddle; Lionel Hebbard; Jacob George
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

5.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

6.  Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.

Authors:  Debashis Haldar; Barbara Kern; James Hodson; Matthew James Armstrong; Rene Adam; Gabriela Berlakovich; Josef Fritz; Benedikt Feurstein; Wolfgang Popp; Vincent Karam; Paolo Muiesan; John O'Grady; Neville Jamieson; Stephen J Wigmore; Jacques Pirenne; Seyed Ali Malek-Hosseini; Ernest Hidalgo; Yaman Tokat; Andreas Paul; Johann Pratschke; Michael Bartels; Pavel Trunecka; Utz Settmacher; Massimo Pinzani; Christophe Duvoux; Philip Noel Newsome; Stefan Schneeberger
Journal:  J Hepatol       Date:  2019-05-07       Impact factor: 25.083

7.  From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.

Authors:  Kenneth I Zheng; Jian-Gao Fan; Jun-Ping Shi; Vincent Wai-Sun Wong; Mohammed Eslam; Jacob George; Ming-Hua Zheng
Journal:  Chin Med J (Engl)       Date:  2020-10-05       Impact factor: 2.628

8.  PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.

Authors:  Jonel Trebicka; Javier Fernandez; Maria Papp; Paolo Caraceni; Wim Laleman; Carmine Gambino; Ilaria Giovo; Frank Erhard Uschner; Christian Jansen; Cesar Jimenez; Rajeshwar Mookerjee; Thierry Gustot; Agustin Albillos; Rafael Bañares; Peter Jarcuska; Christian Steib; Thomas Reiberger; Juan Acevedo; Pietro Gatti; Debbie L Shawcross; Stefan Zeuzem; Alexander Zipprich; Salvatore Piano; Thomas Berg; Tony Bruns; Karen Vagner Danielsen; Minneke Coenraad; Manuela Merli; Rudolf Stauber; Heinz Zoller; José Presa Ramos; Cristina Solé; Germán Soriano; Andrea de Gottardi; Henning Gronbaek; Faouzi Saliba; Christian Trautwein; Haluk Tarik Kani; Sven Francque; Stephen Ryder; Pierre Nahon; Manuel Romero-Gomez; Hans Van Vlierberghe; Claire Francoz; Michael Manns; Elisabet Garcia-Lopez; Manuel Tufoni; Alex Amoros; Marco Pavesi; Cristina Sanchez; Michael Praktiknjo; Anna Curto; Carla Pitarch; Antonella Putignano; Esau Moreno; William Bernal; Ferran Aguilar; Joan Clària; Paola Ponzo; Zsuzsanna Vitalis; Giacomo Zaccherini; Boglarka Balogh; Alexander Gerbes; Victor Vargas; Carlo Alessandria; Mauro Bernardi; Pere Ginès; Richard Moreau; Paolo Angeli; Rajiv Jalan; Vicente Arroyo
Journal:  J Hepatol       Date:  2020-11-20       Impact factor: 25.083

9.  Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality.

Authors:  Vinay Sundaram; Rajiv Jalan; Parth Shah; Ashwani K Singal; Arpan A Patel; Tiffany Wu; Mazen Noureddin; Nadim Mahmud; Robert J Wong
Journal:  Hepatology       Date:  2021-03-25       Impact factor: 17.425

View more
  1 in total

Review 1.  Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease.

Authors:  Xin-Lei Zhang; Ting-Yao Wang; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Diabetes Metab J       Date:  2022-05-25       Impact factor: 5.893

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.